238 related articles for article (PubMed ID: 24998577)
1. Influence of ribosomal protein L39-L in the drug resistance mechanisms of lacrimal gland adenoid cystic carcinoma cells.
Ye Q; Ding SF; Wang ZA; Feng J; Tan WB
Asian Pac J Cancer Prev; 2014; 15(12):4995-5000. PubMed ID: 24998577
[TBL] [Abstract][Full Text] [Related]
2. Effects of ribosomal protein l39-L on the drug resistance mechanisms of lung cancer A549 cells.
Liu HS; Tan WB; Yang N; Yang YY; Cheng P; Liu LJ; Wang WJ; Zhu CL
Asian Pac J Cancer Prev; 2014; 15(7):3093-7. PubMed ID: 24815453
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance effects of ribosomal protein L24 overexpression in hepatocellular carcinoma HepG2 cells.
Guo YL; Kong QS; Liu HS; Tan WB
Asian Pac J Cancer Prev; 2014; 15(22):9853-7. PubMed ID: 25520117
[TBL] [Abstract][Full Text] [Related]
4. [The expression of MMP-2 and MMP-9 in adenoid cystic carcinoma of lacrimal gland].
Zhang L; Zhang H; Song GX; Lin TT; Xu GC; Zhu LM
Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):58-63. PubMed ID: 23601468
[TBL] [Abstract][Full Text] [Related]
5. Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma.
Koo JS; Yoon JS
Am J Clin Pathol; 2015 Apr; 143(4):584-92. PubMed ID: 25780012
[TBL] [Abstract][Full Text] [Related]
6. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland.
Le Tourneau C; Razak AR; Levy C; Calugaru V; Galatoire O; Dendale R; Desjardins L; Gan HK
Br J Ophthalmol; 2011 Nov; 95(11):1483-9. PubMed ID: 21183517
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical features of lacrimal gland epithelial tumors.
Mendoza PR; Jakobiec FA; Krane JF
Am J Ophthalmol; 2013 Dec; 156(6):1147-1158.e1. PubMed ID: 23972314
[TBL] [Abstract][Full Text] [Related]
8. Expression of Autophagy and Reactive Oxygen Species-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma.
Koo JS; Kim JW; Yoon JS
Yonsei Med J; 2016 Mar; 57(2):482-9. PubMed ID: 26847304
[TBL] [Abstract][Full Text] [Related]
9. Genome Sequencing and Apoptotic Markers to Assess Treatment Response of Lacrimal Gland Adenoid Cystic Carcinoma to Intra-Arterial Cytoreductive Chemotherapy.
Yu MD; Men CJ; Do H; Colevas AD; Lin JH; Egbert PR; Tse DT; Kossler AL
Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):e44-e47. PubMed ID: 34798653
[TBL] [Abstract][Full Text] [Related]
10. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma.
Zhang M; Fathy C; Breazzano MP; Hollar M; Barahimi B
Int Ophthalmol Clin; 2017; 57(1):143-152. PubMed ID: 27898620
[No Abstract] [Full Text] [Related]
12. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
[TBL] [Abstract][Full Text] [Related]
13. Disease recurrence after intraarterial chemotherapy in 2 patients with adenoid cystic carcinoma of lacrimal gland.
Fellman M; Carter K; Call CB; Esmaeli B
Can J Ophthalmol; 2013 Apr; 48(2):e17-8. PubMed ID: 23561610
[No Abstract] [Full Text] [Related]
14. Adjuvant chemotherapy in lacrimal gland adenoid cystic carcinoma.
Meel R; Pushker N; Bakhshi S
Pediatr Blood Cancer; 2009 Dec; 53(6):1163-4. PubMed ID: 19743515
[No Abstract] [Full Text] [Related]
15. Bone invasion by adenoid cystic carcinoma of the lacrimal gland: preoperative imaging assessment and surgical considerations.
Williams MD; Al-Zubidi N; Debnam JM; Shinder R; DeMonte F; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2010; 26(6):403-8. PubMed ID: 20924298
[TBL] [Abstract][Full Text] [Related]
16. [Primary culture and morphological characteristics of human lacrimal adenoid cystic carcinoma cells].
Zhou BQ; He YJ; Lin TT; Zhu LM
Zhonghua Yan Ke Za Zhi; 2013 Oct; 49(10):902-8. PubMed ID: 24433692
[TBL] [Abstract][Full Text] [Related]
17. Adenoid cystic carcinoma of the lacrimal gland: rare … lethal … cured?
Bradley EA; Bradley DJ
Ophthalmology; 2013 Jul; 120(7):1311-2. PubMed ID: 23823505
[No Abstract] [Full Text] [Related]
18. Does intra-arterial chemotherapy improve survival for lacrimal gland adenoid cystic carcinoma?
Esmaeli B
Ophthalmology; 2014 Jan; 121(1):e7-e8. PubMed ID: 24268857
[No Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1ɑ) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome.
Anjum S; Sen S; Chosdol K; Bakhshi S; Kashyap S; Pushker N; Bajaj MS; Meel R; Sharma MC
Ann Diagn Pathol; 2022 Feb; 56():151846. PubMed ID: 34749048
[TBL] [Abstract][Full Text] [Related]
20. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
